论文信息 - FluCam—a New, 4-Weekly Combination of Fludarabine and Alemtuzumab for Patients with Relapsed Chronic Lymphocytic Leukemia. - 字舞流文

FluCam—a New, 4-Weekly Combination of Fludarabine and Alemtuzumab for Patients with Relapsed Chronic Lymphocytic Leukemia.

M. Hallek | P. Staib | M. Reiser | S. Trelle | A. Engert | H. Schulz | T. Elter | T. Schinköthe | P. Bochmann